Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Pearlman currently holds 51,730 shares of MEDGENICS, INC. (MDGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Pearlman has been a net seller of MDGN stock. They have purchased $0 and sold $1.3M worth of shares.
Andrew Pearlman's most recent insider trade was on Feb 12, 2014, when they sold 11,168 shares at $3.14 per share.
Andrew Pearlman serves as Executive at MEDGENICS, INC. (MDGN). They have executed 21 insider transactions totaling $1.3M over their tenure at the company.
Andrew Pearlman holds the position of Executive at MEDGENICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Andrew Pearlman has shown a selling trading pattern, with $0 in total purchases and $1.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew Pearlman was on Sep 11, 2012, when they sold $671.8K worth of MDGN shares. This transaction involved 91,403 shares at $7.35 per share.
Andrew Pearlman currently owns 51,730 shares of MEDGENICS, INC. (MDGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Pearlman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Pearlman has 21 Form 4 filings on record as an insider at MEDGENICS, INC..
Set alerts for Andrew Pearlman and 40,000+ other insiders.